Related Experiment Video
Updated: May 14, 2026
07:53
Multidimensional Coculture System to Model Lung Squamous Carcinoma Progression
Published on: March 17, 2020
Multisystemic Langerhans cell histiocytosis with advanced lung involvement
Ricardo Andrade Fernandes de Mello1, Joana Waked Tanos, Melissa Bozzi Nonato Mello
1Department of Radiology, UFES, Vitória, Brazil. ricardoafmello@gmail.com
Journal of Radiology Case Reports
|February 2, 2013
Summary
Langerhans cell histiocytosis (LCH) is a rare disorder of unknown origin. Early diagnosis and staging using imaging are crucial for effective treatment and monitoring of LCH patients.
Area of Science:
- Oncology
- Pathology
- Radiology
Background:
- Langerhans cell histiocytosis (LCH) is a rare neoplastic proliferation of Langerhans cells.
- The etiology of LCH remains unknown, contributing to diagnostic challenges.
Observation:
- LCH presents with a broad clinical spectrum, from localized lesions to multisystemic involvement.
- Diagnostic difficulty arises from the diverse clinical manifestations of LCH.
Findings:
- Accurate disease staging is essential for tailoring LCH treatment strategies.
- Imaging modalities are pivotal for LCH diagnosis and extent assessment.
Implications:
- Effective staging guides appropriate patient management and monitoring in LCH.
- Advanced imaging techniques improve the diagnostic accuracy and therapeutic guidance for LCH.
